🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

AYTU AYTU

Company Profile ↓
$2.30
-13.21% 1Y
P/E-0.45
52W High$2.90
52W Low$1.71
EPS (TTM)$-5.11

Company Overview

AYTU (AYTU) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 89.4% CAGR over the past five years.

Recent Developments

  • Jun 2025 Revenue of $66.38M (+1.8% YoY); net profit $-13.56M.
  • Trailing 12 Months Year-on-year growth — revenue +1.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 89.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:89.42%
1 Year:1.84%

Stock Price Performance

1 Year:-13.21%
6 Months:-12.21%
3 Months:-10.51%
1 Month:+2.22%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 50% of range
$1.71 $2.90
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMABelow
  • RSI (14)59.26 · Neutral
Price Performance
1M+2.22%
3M-10.51%
6M-12.21%
1Y-13.21%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 89.4% over 5 years.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.45
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
89.42%
Profit 5Y
-
Revenue (YoY)
1.84%
Earnings (YoY)
-

Profitability & Returns

ROCE
-12.81%
ROE
-71.51%
ROA
-10.92%
Profit Margin
-20.43%
Op Margin
-11.79%
Gross Margin
69.04%
EPS (Latest Qtr)
$-0.53
EPS (TTM)
$-5.11

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$111.69M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
8.98%
Chg in Prom Hold
-
FII / Inst Holding
36.77%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$66.38M
EBITDA
-
Free Cash Flow
$-2.17M
Operating Cash Flow
$-1.94M
Shares Outstanding
-
Gross Margin
69.04%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2014May 2014Sep 2014Nov 2014Dec 2014Feb 2015Mar 2015Sep 2015Dec 2015Mar 2016Sep 2016Dec 2016Mar 2017Sep 2017Dec 2017Mar 2018Sep 2018Dec 2018Mar 2019Sep 2019Dec 2019Mar 2020Sep 2020Dec 2020Mar 2021Sep 2021Dec 2021Mar 2022Sep 2022Dec 2022Mar 2023Sep 2023Dec 2023Mar 2024Sep 2024Dec 2024Mar 2025Sep 2025Dec 2025Mar 2026
Revenue ----------------------13.52M15.15M13.48M21.90M23.12M24.20M27.66M26.28M22.73M17.82M18.75M14.03M16.57M16.22M18.45M13.89M15.16M12.41M
Gross Profit ----------------------9.46M8.90M-452.00K12.46M12.30M12.69M18.03M17.29M12.74M13.04M14.60M10.36M11.98M10.79M12.81M9.19M9.62M7.60M
Operating Income --11.13K-2.09M-15.29K-1.58M-9.40K-1.81M-2.16M-3.01M-3.23M-5.97M-4.20M-4.86M-4.36M-3.99M-7.52M-3.42M-4.55M-4.30M-4.74M-4.97M-4.79M-3.56M-5.58M-25.67M-27.70M-11.29M-53.42M-1.81M-6.87M-8.56M-867.00K3.15M-1.60M-930.00K-1.70M2.42M-1.50M-1.97M-4.06M
Net Income -1.68M-11.82K-2.11M-15.75K-1.62M-9.88K-1.84M-2.28M-3.33M-7.27M-5.72M-4.82M-5.22M-4.25M-3.67M-2.82M-3.45M-4.66M-4.50M-4.93M-214.25K-5.33M-4.31M-9.53M-25.46M-27.85M-11.55M-53.29M-701.00K-6.69M-7.20M-8.12M-220.00K-2.89M1.47M788.00K3.99M1.97M-10.58M-5.62M
Diluted EPS -----------------------0.35-0.72-1.41-1.09-8.74-35.90-0.28-2.15-1.93-1.48-0.04-0.52-0.15-0.260.21-0.08-1.05-0.53
R&D Expense 1.24M-933.75K-789.97K-694.18K855.87K1.31M1.14M232.02K263.46K279.05K140.95K-277.49K114.14K155.88K149.03K108.90K78.02K66.67K78.50K183.00K286.00K390.00K1.65M4.47M3.28M1.06M1.71M856.00K595.00K521.00K611.00K426.00K522.00K162.00K000

Profit & Loss (Annual)

Figures in USD.

Metric Aug 2006Aug 2007Aug 2008Aug 2009Aug 2010Aug 2011Aug 2012Aug 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Revenue --------58.93K261.78K2.56M3.22M3.66M7.32M27.63M65.63M96.67M107.40M65.18M66.38M
Gross Profit --------------19.35M29.20M52.28M66.63M49.05M45.83M
Operating Income ------133.62K-56.36K-52.41K-6.35M-7.63M-21.70M-20.13M-19.70M-16.85M-21.13M-58.87M-109.91M-17.07M-1.59M-7.83M
Net Income -70.44K-48.95K-57.17K-58.89K-60.27K-136.80K-59.67K-57.32K-5.58M-7.72M-28.18M-22.51M-10.19M-27.13M-13.62M-58.29M-108.78M-17.05M-15.84M-13.56M
Diluted EPS ----------------3.48-74.01-5.11--
R&D Expense --------3.93M3.22M6.13M959.86K167.59K589.07K1.72M5.62M12.66M4.09M2.77M1.33M

Balance Sheet (Annual)

Figures in USD.

Metric Feb 2005Aug 2005Aug 2006Aug 2007Aug 2008Aug 2009Aug 2010Aug 2011Aug 2012Jun 2013Aug 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Total Assets -------22.84K12.65K-9.67K12.02M18.19M24.34M15.00M21.06M34.72M153.29M265.67M137.62M136.46M118.09M124.18M
Total Equity 10020.42K57.95K18.81K25.96K-13.58K-55.61K-35.59K-69.72K9.81M-110.86K5.37M15.62M10.09M4.00M13.42M7.09M95.02M137.57M44.31M39.36M27.72M18.97M
Cash & Equivalents ---------2.91M-2.64M7.35M8.05M802.33K7.01M11.04M48.08M49.65M19.36M22.98M20.01M30.95M
Long Term Debt -------------------15.00M14.71M10.88M10.89M
Total Liabilities -----------6.65M2.57M14.26M11.00M7.64M27.63M58.28M128.10M93.31M97.11M--
Current Liabilities -------58.43K82.36K-120.53K6.09M1.48M10.10M3.61M3.39M5.37M28.76M109.44M64.44M69.02M62.23M63.06M

Cash Flows (Annual)

Figures in USD.

Metric Aug 2011Aug 2012Aug 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Operating Cash Flow -64.82K-37.85K-37.70K----13.83M-15.94M-13.83M-28.37M-25.96M-28.82M-5.13M-1.39M-1.94M
Investing Cash Flow -------3.53M-484.29K-1.06M-5.66M-2.78M-3.25M-117.00K-329.00K-2.56M
Financing Cash Flow 67.27K33.97K39.46K---10.19M22.66M19.08M71.07M30.31M1.53M8.87M-1.26M15.44M
Capital Expenditure ----9.30K-0-252.93K-111.61K-74.71K-59.85K-0----329.00K-228.00K
Free Cash Flow -------13.94M-16.02M-13.89M-28.37M----1.72M-2.17M

Ratios (Annual)

Figures in %.

Metric Aug 2006Aug 2007Aug 2008Aug 2009Aug 2010Aug 2011Aug 2012Aug 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Gross Margin % --------------70.0%44.5%54.1%62.0%75.3%69.0%
Operating Margin % ---------10,770.3%-2,915.5%-847.0%-624.7%-538.2%-230.1%-76.5%-89.7%-113.7%-15.9%-2.4%-11.8%
Net Margin % ---------9,466.8%-2,950.3%-1,099.7%-698.7%-278.3%-370.6%-49.3%-88.8%-112.5%-15.9%-24.3%-20.4%
ROE % -121.6%-260.3%-220.3%433.6%108.4%384.3%85.6%51.7%-103.9%-49.5%-279.4%-562.7%-75.9%-382.8%-14.3%-42.4%-245.5%-43.3%-57.2%-71.5%
ROCE % -----375.4%80.8%47.3%-107.1%-45.7%-152.4%-176.7%-111.5%-57.4%-17.0%-37.7%-150.2%-25.3%-2.8%-12.8%

Shareholding Pattern

Insiders
8.98%
Institutions
36.77%
Public Float
40.40%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AYTU

Google News Sat, 20 Dec 2025

Aytu BioPharma, Inc. (NASDAQ:AYTU) Stock Catapults 28% Though Its Price And Business Still Lag The Industry - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPcnZzdTJGejRLVDdmOW1zblczTS1tVWloVjU2NE83UHJwWDJVS2xlZ2lBUmR5OWtnZG9WbzRadHhpekkwREo0aWdSbkR2cmtra29hOEh0ODRKUmRKOEZjMk5VNVZBMEVKdHpKX0pLbjFGc0JfRFJYMHhyUTZNdmk1WFRManozUElFTDM4Z3…

Google News hu, 16 Jul 2026

New Strong Sell Stocks for July 16th - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNMWpOZnVXYXBHbDFhU2w5ekRDVlI0N0ZoUFdSWnRuczV4QzktSVZYZVI2LUVqZTR2ZEQ4VnhuMldZRGxVWFg2OGpYZHZDOThFb1ZLd2VkaEJYcDB2SVY4ZEhoczU4aEtheDJqbnVpY0FmVjd2ZkVrcC1raGNCT1g0ZDZKSTU3SzlXbHZuRE…

Google News Fri, 31 Jul 2026

AYTU|Aytu Biopharma Inc|Price:2.230|Chg%:+0.080 - TradingKey

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBEb2cyQks1ejBJLWN1V2lnUXZEOGF5Zm9sV2VzTFc2T1I3WkxKOUJUT24tbHlLS0RyVjRjUXV3Y0lvRF81N1ZIaGMzakltWDZqWmU5ZzAxRlpMalVkbnFIQTIxQ0d3UzdRWV9yZlhB?oc=5" target="_blank">AYTU|Aytu Biopharma…

Google News Sat, 25 Jul 2026

Aytu BioPharma, Inc. Revenue Breakdown – NASDAQ:AYTU - TradingView

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9tSGRMWHltdHBPVU1VSTc4allhVFNzNlA1d3VZV3FmTmN6V0hwcDZMeFdLNGp1bmdJOFlFZndDNTlPSzJWcWRsa3hQbVgySnpsRDdsNTNncGZGcGVVVGFLal84c09taXFBZy1mN1l6VVE3WWJTakdR?oc=5" target="_blank">Aytu Bi…

Google News Wed, 13 May 2026

AYTU BIOSCIENCE ($AYTU) Releases Q3 2026 Earnings - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxOckpjcWVhYjU4T0dfR1VmenhFVXJkckpva2t3WXp3dktzNmkwQ2dGaS12VTVhZlQ1Z1ZGbm43M252YUU3UnF6ejhLYnk5SFJBWnEzVVJ4WWFKcmcyMjBnbHh0NVYyLTZnVWRKNVVIZFRmQnBQdmN6dHhkakdFcWZ3aXE0bzFUUkxFN2c?oc…

Google News hu, 30 Jul 2026

Aytu BioScience (AYTU) Q2 2026 Earnings Report - Results, Call & Slides - TipRanks

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1fckJhVTBDUnktbk9nc1pSck1FZTYzb1l6azk1Qm1yZzJqNzBPMGpfNzVaY0psQWNGSDEtWHNCbmtyS21kUUh1b0FuR0pETE9DYlVvRDJuYjJGbVdGcmItUWRkSE9vRi1OaTAtTQ?oc=5" target="_blank">Aytu BioScience (AYTU…

AYTU — Frequently Asked Questions

What is the current share price of AYTU?

As of 2026-08-05 17:25 PDT, AYTU trades at $2.30 on NASDAQ/NYSE. Its 52-week range is $1.71 to $2.90.

What is the P/E ratio of AYTU?

AYTU trades at a trailing price-to-earnings (P/E) ratio of -0.45.

What is the return on equity (ROE) of AYTU?

AYTU has a return on equity (ROE) of -71.51%. Its return on capital employed (ROCE) is -12.81%.

Is AYTU a good stock to buy?

This page provides a data-driven analysis of AYTU, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space